{"id":"placebo-ambulatory-cohort-only","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL464738","moleculeType":"Small molecule","molecularWeight":"396.48"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used in randomized controlled trials to establish baseline efficacy and safety of an investigational drug. In this phase 3 ambulatory cohort study by Taiho Pharmaceutical, placebo provides the control arm against which the active investigational agent is compared. Any observed effects in the placebo group reflect natural disease progression, regression to the mean, and the placebo effect.","oneSentence":"Placebo has no active pharmacological mechanism; it serves as a control comparator in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:33.292Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":464,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo [Ambulatory Cohort] only","genericName":"Placebo [Ambulatory Cohort] only","companyName":"Taiho Pharmaceutical Co., Ltd.","companyId":"taiho-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}